로딩 중…
지수 로딩 중…
Eton Pharmaceuticals, Inc.
ETON· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$32.48-0.85%
2026-06-18
Price Chart
Eton Pharmaceuticals, Inc.+137.08%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $890M |
| Revenue | $87M |
| Net Income | $-1M |
| Total Assets | $98M |
| Net Assets | $31M |
| Value | |
| P/B | 29.06x |
| P/S | 10.23x |
| EV/EBITDA | 154.84x |
| FCF Yield | 1.73% |
| Profitability | |
| ROE | -4.82% |
| ROA | -1.51% |
| Op. Margin | 2.35% |
| Revenue Growth | 40.41% |
| Financial Health | |
| Debt Ratio | 219.16% |
| Total Debt | $12M |
| FCF | $15M |
| Cash | $20M |
| Current Ratio | 1.21x |
| Net Debt/EBITDA | -1.30x |
| Performance | |
| 1Y Return | 137.08% |
| 1M Return | -1.25% |
| From 52W High | -8.92% |
| 1Y MDD | -36.17% |
| Trading | |
| Volume | 582,797 shares |
| Trading Value | $19M |
| Per Share | |
| EPS | $-0.17 |
| BPS | $0.97 |